A note from the founder.

I built this because I am the person it is for.

I am in my early fifties. I have been practicing what the longevity world now calls a “protocol” for years — long before that word attached itself to supplement stacks and biohacking podcasts. I track my blood markers. I have worked with physicians. I have read studies, sometimes carefully, sometimes not carefully enough.

And I have made mistakes that better information would have prevented. Not catastrophic ones — but the quiet kind: adding a compound before the evidence was adequate, continuing a practice because it felt productive rather than because anything I could measure suggested it was. The mistakes that come from optimism outrunning rigor.

The longevity market is saturated with enthusiasm and thin on quality evidence handling. There are excellent researchers — a small number of genuinely rigorous clinicians and scientists working in this space — and there is an enormous, fast-moving commercial ecosystem that moves far faster than the evidence and relies on the consumer's difficulty in distinguishing between the two.

Temple Protocol is my attempt to be useful at that gap. Not a supplement brand. Not a clinic. Not a platform designed to make you feel like you are falling behind if you are not adding something. An editorial practice that takes the question seriously and holds itself to a published evidence standard.

The audience is adults between fifty and seventy-five who are already engaged — people who have spent real money and real attention on their health, who are skeptical of the influencer economy, and who want better information without the noise. People who, like me, have learned enough to know what they don't know.

The product side — the Bio Stack Audit — exists because the specific problem of interaction analysis across a complex stack has no good solution at a reasonable cost. A functional medicine physician will do it for $500 an hour. The rest of the market offers supplement brand marketing dressed as research. There is space for something honest.

What this will never become: a content operation built around affiliate revenue. A supplement brand with an editorial veneer. A platform that monetizes anxiety. If the editorial and the commercial interest ever come into conflict, the editorial wins, or we stop.

— Aaron De Young